(NTLA) Intellia Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Intellia Therapeutics | (NTLA) share price targets
Complete technical analysis of Intellia Therapeutics (NTLA) by charts plus indicators, forecast predictions and share price targets for Intellia Therapeutics (NTLA)
Intellia Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-07-08 View latest technical analysis
10 day averaged volume of Intellia Therapeutics is 1920160
Date | Daily Closing Price | Open | High | Low | Volume |
08 Mon Jul 2024 | 22.94 | 23.16 | 23.39 | 22.82 | 0.934 times |
05 Fri Jul 2024 | 22.76 | 22.80 | 22.96 | 22.16 | 0.585 times |
03 Wed Jul 2024 | 22.95 | 22.42 | 23.15 | 22.15 | 0.439 times |
03 Wed Jul 2024 | 22.95 | 22.42 | 23.15 | 22.15 | 0.439 times |
02 Tue Jul 2024 | 22.15 | 22.44 | 22.46 | 21.60 | 0.747 times |
01 Mon Jul 2024 | 22.47 | 22.11 | 23.43 | 22.06 | 0.672 times |
28 Fri Jun 2024 | 22.38 | 23.19 | 23.20 | 21.78 | 2.808 times |
27 Thu Jun 2024 | 23.19 | 22.98 | 23.54 | 22.71 | 0.795 times |
26 Wed Jun 2024 | 22.91 | 23.86 | 23.86 | 21.91 | 1.28 times |
25 Tue Jun 2024 | 24.00 | 24.70 | 24.84 | 23.97 | 0.87 times |
My analysis of stock is bearish for shortterm, but stock is semi over sold and there are some chances of seeing a recovery tomorrow. Use 22.7 as stoploss in an intra day buy trade for a target of 23.88. However, stock will show a bearish move below 22.7.
Share price targets for Intellia Therapeutics (NTLA)
Target Type | Value |
Downside Target | 19.37 |
Downside Target | 21.31 |
Downside Target | 22.82 |
Upside Target | 23.45 |
Upside Target | 25.17 |
Upside Target | 26.06 |
Upside Target | 26.93 |
Upside Target | 26.98 |
Upside Target | 27.17 |
Upside Target | 27.46 |
Upside Target | 34.01 |
Intraday share price targets for Intellia Therapeutics (NTLA)
Target Type | Value |
Downside Intraday Target | 22.71 |
Downside Intraday Target | 22.48 |
Upside Intraday Target | 23.28 |
Upside Intraday Target | 23.62 |
Upside Intraday Target | 23.05 |
Weekly technical analysis of Intellia Therapeutics (NTLA)
Date | Weekly Closing Price | Open | High | Low | Volume |
08 Mon Jul 2024 | 22.94 | 23.16 | 23.39 | 22.82 | 0.912 times |
05 Fri Jul 2024 | 22.76 | 22.42 | 23.15 | 22.15 | 0.551 times |
03 Wed Jul 2024 | 22.95 | 22.11 | 23.43 | 21.60 | 0.261 times |
28 Fri Jun 2024 | 22.38 | 26.21 | 26.93 | 21.78 | 2.315 times |
21 Fri Jun 2024 | 24.22 | 25.13 | 25.17 | 23.45 | 2.254 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Intellia Therapeutics (NTLA)
Date | Monthly Closing Price | Open | High | Low | Volume |
08 Mon Jul 2024 | 22.94 | 22.11 | 23.43 | 21.60 | 0.177 times |
28 Fri Jun 2024 | 22.38 | 22.60 | 26.98 | 21.78 | 1.295 times |
31 Fri May 2024 | 21.38 | 21.33 | 27.17 | 21.31 | 1.199 times |
30 Tue Apr 2024 | 21.40 | 27.43 | 27.46 | 19.37 | 0.99 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Intellia Therapeutics (NTLA)
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.78 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Intellia Therapeutics ( (NTLA) ) based on a mid to longer term time period is neutral. A longer time frame might give a better analysis.
ADX buy sell signal for Intellia Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Intellia Therapeutics in short term and the sell signal is strong.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Intellia Therapeutics Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are below the red cloud Prices appear to be moving up
CCI has generated a buy signal for Intellia Therapeutics in short term and BUY signal is strong.
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in negative zone. This is the SELL zone
Stock of Intellia Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 22.78 and Intellia Therapeutics (NTLA) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Intellia Therapeutics (NTLA) stock. Volume based technical analysis of Intellia Therapeutics (NTLA) stock is negative.
Intellia Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.